Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

58.01 +0.91 (+1.59%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
48 49 Next >
CVS Health Unusual Options Activity For February 02
Via Benzinga
Wall Street Favorites: 3 Undervalued Stocks With Strong Buy Ratings for January 2024
Although it may be tempting to ride the coattails of the usual suspects, investors should consider undervalued stocks January 2024. 
Via InvestorPlace
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions. 
Via Benzinga
Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance 
Via MarketBeat
Check Out What Whales Are Doing With CVS
Via Benzinga
Peering Into CVS Health's Recent Short Interest
Via Benzinga
Wall Street HATES These Three Stocks
Professional investors on Wall Street are betting against a handful of consumer stocks. 
Via Talk Markets
Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape. 
Via Benzinga
Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion. 
Via Benzinga
Humana Dives On Huge 2024 Earnings Warning
The health insurer says earnings will be barely half of estimates. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
P/E Ratio Insights for CVS Health
Via Benzinga
Check Out What Whales Are Doing With CVS
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
MarketBeat Week in Review – 1/15 - 1/19
The market continues to bounce back and forth as investors wait on news from the Federal Reserve later this month, but inflation may still be the bigger story 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
The "buy everything" sentiment that powered equity indices higher last quarter is over. It's a stock picker's market, Marc Chaikin says. 
Via Benzinga
Medicare Patients Alert! Biden Administration Finalizes Rule to Streamline Health Insurance Prior Authorization
Biden Administration's rule for health information exchange and prior authorization processes in government-backed insurance plans. Streamlined procedures, reduced wait times, and estimated $15 billion... 
Via Benzinga
Humana Stock Falls Ill On This Warning; UNH, CVS Catch Virus
Humana slashed its Q4 earnings outlook on higher medical costs and warned about weak Medicare Advantage enrollment. 
Via Investor's Business Daily
Healthcare Insurance Giant Humana Stock Hits 52-Week Low Today - Here's Why
Humana revises fiscal 2023 earnings outlook, citing higher-than-expected healthcare costs. 2023 adjusted earnings now at $26.09/share, down from earlier forecast of $28.25/share. 
Via Benzinga
Are CVS store closures prescription for better financial health?
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
If You Can Only Buy One Blue-Chip Stock in January, It Better Be One of These 7 Names
If you’re looking for reliability, smart investors can’t go wrong with most of the blue-chip stocks, with dividends to boot. 
Via InvestorPlace
3 Stocks to Profit from the Telehealth Transformation
Telehealth stocks capture healthcare and medicine's future but don't bet the bank on a company that can't cut it. 
Via InvestorPlace
CVS Health Adapts to Market Shifts With Pharmacy Shutdowns Within Target Stores
CVS Health's strategic pharmacy changes within Target stores. Closures from Feb to Apr due to market dynamics. Prescription transfers to nearby CVS locations. 
Via Benzinga
Can My Portfolio’s 3 Worst Stocks From 2023 Rebound in 2024?
The least shall be first. I'm hoping for these underperforming companies to become rebounding stocks this year. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Stocks to Capitalize on the Telehealth Explosion
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
24 Top Dividend Stocks to Buy and Hold in 2024
These stocks could deliver positive gains in the new year -- but the real money-making opportunities are over the next decade and beyond. 
Via The Motley Fool
Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada
The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and afford their medications.  
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.